Investing.com — As we step into 2025, markets are navigating a delicate balance between optimism and caution. The past year saw remarkable gains, with the S&P 500 posting its best…
SHANGHAI (Reuters) – People’s Bank of China Governor Pan Gongsheng met his Bank of England counterpart, Andrew Bailey, on Saturday in Beijing and discussed topics including financial stability and cooperation,…
Investing.com — Agentic AI, identified as the next major wave in artificial intelligence, is poised to redefine the landscape of technology and its applications. According to analysts at BofA Global…
Apple’s board recommends shareholders vote against proposal to eliminate diversity programs
(Reuters) – Apple (NASDAQ:AAPL)’s board of directors recommended investors vote against a shareholder proposal to abolish the company’s Diversity, Equity, and Inclusion (DEI) programs, according to a proxy filing from…
(Reuters) – Meta Platforms (NASDAQ:META) and Amazon.com (NASDAQ:AMZN) have joined a growing number of U.S. companies in scaling back their diversity, equity, and inclusion (DEI), meant to boost racial and…
SHANGHAI (Reuters) – People’s Bank of China Governor Pan Gongsheng met his Bank of England counterpart, Andrew Bailey, on Saturday in Beijing and discussed topics including financial stability and cooperation,…
By Sai Ishwarbharath B and Haripriya Suresh BENGALURU/MUMBAI (Reuters) – India’s Tata Consultancy Services (NS:TCS) expects its retail and manufacturing clients in North America to step up spending on tech,…
Investing.com — U.S. Treasury yields may decline in the near term as economic data and Federal Reserve signals align to ease market pressures, according to analyst Adam Crisafulli. Encouraging signs in…
5 big analyst AI moves: Tesla, AMD, Adobe downgraded; Salesforce top pick for 2025
Investing.com — Here are the biggest analyst moves in the area of artificial intelligence (AI) for this week. InvestingPro subscribers always get first dibs on market-moving AI analyst comments. Upgrade…
Investing.com — Bernstein analysts are optimistic about the European pharmaceutical sector as it heads into 2025, despite concerns over policy changes and market headwinds. The firm outlined its three key reasons…